Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease.
作者信息
Cooper D S
机构信息
Division of Endocrinology, Sinai Hospital of Baltimore, Maryland, USA.
出版信息
Endocrinol Metab Clin North Am. 1998 Mar;27(1):225-47. doi: 10.1016/s0889-8529(05)70308-x.
PMID:9534038
Abstract
Therapy for Graves' disease is not straightforward and often involves complex decision making. Long-term antithyroid drug therapy is appealing because it is nonablative, but it is not for everyone. The physician must weigh the advantages and disadvantages of antithyroid drug treatment and help the patient arrive at an individualized therapeutic strategy that is appropriate and cost-effective.
摘要
Zotero 插件